ES446939A1 - Process for the enrichment of pregnancy specific -glycoprrotein - Google Patents

Process for the enrichment of pregnancy specific -glycoprrotein

Info

Publication number
ES446939A1
ES446939A1 ES446939A ES446939A ES446939A1 ES 446939 A1 ES446939 A1 ES 446939A1 ES 446939 A ES446939 A ES 446939A ES 446939 A ES446939 A ES 446939A ES 446939 A1 ES446939 A1 ES 446939A1
Authority
ES
Spain
Prior art keywords
enrichment
pregnancy
glycoprrotein
bound
vehicle
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES446939A
Other languages
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens Healthcare Diagnostics GmbH Germany
Original Assignee
Behringwerke AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/569,476 external-priority patent/US4065445A/en
Application filed by Behringwerke AG filed Critical Behringwerke AG
Publication of ES446939A1 publication Critical patent/ES446939A1/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4715—Pregnancy proteins, e.g. placenta proteins, alpha-feto-protein, pregnancy specific beta glycoprotein
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/76—Human chorionic gonadotropin including luteinising hormone, follicle stimulating hormone, thyroid stimulating hormone or their receptors

Abstract

Procedure for the enrichment of β 1-specific glycoprotein of pregnancy (sp1) from blood serum, urine or placenta extract, characterized in that the starting material is contacted, at a ph value between 4 and 9, with an antibody against the β 1-pregnancy-specific glycoprotein, bound to an insoluble vehicle, because the vehicle, which contains sp1 bound, separates from the liquid phase, and is treated with an aqueous medium of ph 2-4 or with a solution of a substance dissociating protein molecules, at a ph of 4-9, for the release of sp1. (Machine-translation by Google Translate, not legally binding)
ES446939A 1975-04-18 1976-04-12 Process for the enrichment of pregnancy specific -glycoprrotein Expired ES446939A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/569,476 US4065445A (en) 1971-09-29 1975-04-18 Pregnancy-specific β1 -glycoprotein and process for isolating it

Publications (1)

Publication Number Publication Date
ES446939A1 true ES446939A1 (en) 1977-12-01

Family

ID=24275609

Family Applications (2)

Application Number Title Priority Date Filing Date
ES446944A Expired ES446944A1 (en) 1975-04-18 1976-04-12 Process for the enrichment of pregnancy specific -glycoprrotein
ES446939A Expired ES446939A1 (en) 1975-04-18 1976-04-12 Process for the enrichment of pregnancy specific -glycoprrotein

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES446944A Expired ES446944A1 (en) 1975-04-18 1976-04-12 Process for the enrichment of pregnancy specific -glycoprrotein

Country Status (18)

Country Link
JP (2) JPS51133406A (en)
AT (2) AT344920B (en)
AU (2) AU503288B2 (en)
BE (2) BE840913A (en)
CA (2) CA1065307A (en)
DE (1) DE2612479A1 (en)
DK (2) DK173876A (en)
ES (2) ES446944A1 (en)
FI (2) FI56184C (en)
FR (2) FR2307815A1 (en)
GB (2) GB1541453A (en)
IE (2) IE42566B1 (en)
IT (1) IT1060215B (en)
LU (2) LU74782A1 (en)
NL (2) NL7603903A (en)
NO (2) NO145405C (en)
NZ (1) NZ180619A (en)
SE (2) SE419340B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2720704C2 (en) * 1977-05-07 1986-09-25 Behringwerke Ag, 3550 Marburg New glycoprotein, process for its production and its uses

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5325030B2 (en) * 1972-12-19 1978-07-24

Also Published As

Publication number Publication date
JPS51133408A (en) 1976-11-19
AU503342B2 (en) 1979-08-30
AU1308176A (en) 1977-10-20
ATA284276A (en) 1977-12-15
FI54486C (en) 1978-12-11
SE7604484L (en) 1976-10-19
AT344734B (en) 1978-08-10
NO145405C (en) 1982-03-17
FR2307815B1 (en) 1979-08-31
AU503288B2 (en) 1979-08-30
LU74783A1 (en) 1977-02-04
IE42679B1 (en) 1980-09-24
CA1065305A (en) 1979-10-30
DE2612479A1 (en) 1976-10-21
IT1060215B (en) 1982-07-10
FI54486B (en) 1978-08-31
GB1541453A (en) 1979-02-28
NO145405B (en) 1981-12-07
ATA284176A (en) 1977-12-15
NL7603903A (en) 1976-10-20
JPS558497B2 (en) 1980-03-04
LU74782A1 (en) 1977-02-04
SE7604483L (en) 1976-10-19
BE840912A (en) 1976-10-20
NO761305L (en) 1976-10-19
JPS51133406A (en) 1976-11-19
IE42566B1 (en) 1980-09-10
FI56184B (en) 1979-08-31
DK173576A (en) 1976-10-19
ES446944A1 (en) 1977-12-01
FI761017A (en) 1976-10-19
NL7603902A (en) 1976-10-20
FR2307816B1 (en) 1980-08-01
FI761016A (en) 1976-10-19
NZ180619A (en) 1978-03-06
BE840913A (en) 1976-10-20
DK173876A (en) 1976-10-19
IE42679L (en) 1976-10-18
AU1308276A (en) 1977-10-20
FI56184C (en) 1979-12-10
CA1065307A (en) 1979-10-30
AT344920B (en) 1978-08-25
IE42566L (en) 1976-10-18
NO761306L (en) 1976-10-19
GB1541454A (en) 1979-02-28
SE419340B (en) 1981-07-27
FR2307816A1 (en) 1976-11-12
FR2307815A1 (en) 1976-11-12

Similar Documents

Publication Publication Date Title
ES398372A1 (en) Process for the detection and determination of specific binding proteins and their corresponding bindable substances
ES396741A1 (en) Process for the demonstration and determination of low molecular compounds and of proteins capable of binding these compounds specifically
Goldwasser et al. Further purification of sheep plasma erythropoietin
Olson et al. Localization of phosphoprotein C23 in nucleoli by immunological methods
ES395315A1 (en) Fish protein isolate
Sacco et al. Localization of tissue-specific antigens in the rabbit ovary, oviduct and uterus by the fluorescent antibody technique
GB1499958A (en) Radioimmunoassay methods for the determination of thyroxine
ES462699A1 (en) Process for the isolation of a placentaspecificglycoprotein
IE42521L (en) Treating a sodium lauryl sulphate-whey protein complex.
ES446939A1 (en) Process for the enrichment of pregnancy specific -glycoprrotein
Cann Effect of binding of ions and other small molecules on protein structure. VII. The role of aliphatic acid binding and of convection in the electrophoresis of serum albumin at low pH
Arzac et al. Demonstration of Golgi zones by three technics for carbohydrates
Polvino et al. Improved protein analysis on nitrocellulose membranes
KR890008313A (en) Anti PCI monoclonal antibody
Gordis Detection of insulin-binding antibodies and separation of free and antibody-bound insulin by rapid chemical procedure
GB1151608A (en) A Method for Determining Vitamin B12
GB987784A (en) A process for the separation of protein antigens from protein mixtures and the production of antisera therefor
ES482215A1 (en) Stabilized platelet factor 4 immunoassay standards and radio-immunoassay method.
Swartz et al. Binding of estrogens by α-fetoprotein in rat amniotic fluid
DE3854096D1 (en) Process for the isolation of basement membrane proteins from human and animal tissues.
GB1223589A (en) Improvements relating to a medium for separations
Chow The purification and properties of certain protein hormones
GB993961A (en) Improvements in or relating to immunochemical polymer preparations
ES459386A1 (en) Process for the functional properties of protein material
Haglid et al. Purification of soluble glycoproteins from human nervous tissue and liver